drugset / Trial / NCT02888171

Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency

NCT02888171

Completed 60 enrolled University of Alabama at Birmingham
RandomizedParallel-groupOpen-labelTreatment

Summary

The main objective of the study is to compare the impact of oral ferric citrate compared to standard of care oral ferrous sulfate on serum iron, percent transferrin saturation, ferritin, hepcidin and hemoglobin levels in individuals with moderate to severe chronic kidney disease (CKD) and absolute iron deficiency.

Timeline

Start
2016-09
Primary completion
2019-02-12
Completion
2019-03-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric Citrate Unknown 2 g Oral
Comparator Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral